Antares Pharma, Inc. (ATRS)

Total Costs & Expenses

$183.29M

TTM · Period ending: · USD

ATRS logo

ATRS Total Costs & Expenses

Latest reported$183.29M
ATRS TTM Total Costs & Expenses ($4.94M → $183.29M)
High-resolution chart · PNG

ATRS total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
183,292,000
175,607,000
153,144,000
147,071,000
138,222,000
135,980,000
130,217,000
128,374,000
129,054,000
122,872,000
115,133,000
102,050,000
90,101,000
80,155,000
73,680,729
74,451,936
72,514,698
70,966,000
71,322,983
70,939,984
73,084,860
76,338,506
76,217,698
73,455,809
71,057,027
66,120,079
66,267,473
63,158,339
62,694,421
61,614,960
53,864,750
51,997,569
47,547,845
41,468,817
41,322,595
38,650,722
34,996,987
34,027,077
29,070,607
25,051,014
22,875,803
20,895,279
19,813,081
19,414,560
18,877,276
18,845,156
19,399,288
19,265,737
18,387,518
18,004,706
17,314,247
17,075,949
17,888,436
17,858,680
18,757,782
18,262,665
17,731,144
16,502,582
14,636,110
13,074,714
12,496,860
12,151,927
11,433,265
11,509,349
10,921,136
10,813,920
11,457,575
11,861,947
11,427,617
11,120,622
11,346,635
11,879,725
12,143,119
12,420,884
14,159,762
13,971,358
14,255,803
14,257,657
13,185,012
12,757,786
12,640,069
12,031,443
10,225,657
9,046,394
7,893,830
6,999,147
6,177,029
6,299,721
6,117,829
6,692,836
8,096,699
8,496,699
8,896,699
8,896,699
7,856,945
7,456,945
7,356,945
7,156,945
7,137,493
6,937,493
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.